Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D13VWF
|
|||
| Drug Name |
MRX-8
|
|||
| Indication | Gram-negative bacterial infection [ICD-11: 1B74-1G40] | Phase 1 | [1] | |
| Company |
MicuRx Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04649541) An Adaptive, Randomized, Double Blind, Placebo Controlled Three Part Study of the Safety, Tolerability, and Pharmacokinetics of MRX-8 Administered Intravenously to Healthy Volunteers in Single Ascending and Multiple Ascending Dose Cohorts. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.